Leptin dose-dependently decreases atherosclerosis by attenuation of hypercholesterolemia and induction of adiponectin

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1862, Issue 1, 2016, Pages 113-120

  Hoffmann, Annett ^a   Ebert, Thomas ^a,b   Klöting, Nora ^b   Dokas, Janine ^a   Jeromin, Franziska ^a   Jessnitzer, Beate ^a   Burkhardt, Ralph ^a   Fasshauer, Mathias ^a,b   Kralisch, Susan ^a,b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Adipokine; Adiponectin; Atherosclerosis; Insulin resistance; Leptin; Obesity

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERMEDIATE DENSITY LIPOPROTEIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; RECOMBINANT LEPTIN; SODIUM CHLORIDE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ROOT; ARTICLE; ATHEROSCLEROSIS; BRACHIOCEPHALIC TRUNK; CONTROLLED STUDY; DOSE RESPONSE; GLUCOSE HOMEOSTASIS; HYPERCHOLESTEROLEMIA; LIPID METABOLISM; LIVER FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84947227837     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2015.10.022     Document Type: Article

References (39)

1. Eckel R.H., Krauss R.M., for the AHA Nutrition Committee American Heart Association call to action: obesity as a major risk factor for coronary heart disease. Circulation 1998, 97:2099-2100.
2. Rodriguez A., Ezquerro S., Méndez-Giménez L., Becerril S., Frühbeck G. Revisiting the adipocyte: a model for integration of cytokine signaling in the regulation of energy metabolism. Am. J. Physiol. Endocrinol. Metab. 2015, (ajpendo.00297.2015).
3. Fasshauer M., Blüher M. Adipokines in health and disease. Trends Pharmacol. Sci. 2015, 36:461-470.
4. Friedman J.M., Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 1998, 395:763-770.
5. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
6. Tartaglia L.A., Dembski M., Weng X., Deng N., Culpepper J., Devos R., Richards G.J., Campfield L.A., Clark F.T., Deeds J., Muir C., Sanker S., Moriarty A., Moore K.J., Smutko J.S., Mays G.G., Wool E.A., Monroe C.A., Tepper R.I. Identification and expression cloning of a leptin receptor. OB-R Cell 1995, 83:1263-1271.
7. Coleman D.L. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 1978, 14:141-148.
8. Montague C.T., Farooqi I.S., Whitehead J.P., Soos M.A., Rau H., Wareham N.J., Sewter C.P., Digby J.E., Mohammed S.N., Hurst J.A., Cheetham C.H., Earley A.R., Barnett A.H., Prins J.B., O'Rahilly S. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997, 387:903-908.
9. Farooqi I.S., Bullmore E., Keogh J., Gillard J., O'Rahilly S., Fletcher P.C. Leptin regulates striatal regions and human eating behavior. Science 2007, 317:1355.
10. Halaas J.L., Gajiwala K.S., Maffei M., Cohen S.L., Chait B.T., Rabinowitz D., Lallone R.L., Burley S.K., Friedman J.M. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995, 269:543-546.
11. Lloyd D.J., McCormick J., Helmering J., Kim K.W., Wang M., Fordstrom P., Kaufman S.A., Lindberg R.A., Véniant M.M. Generation and characterization of two novel mouse models exhibiting the phenotypes of the metabolic syndrome: Apob48-/-Lepob/ob mice devoid of ApoE or Ldlr. Am. J. Physiol. Endocrinol. Metab. 2008, 294:E496-E505.
12. Jun J.Y., Ma Z., Pyla R., Segar L. Leptin treatment inhibits the progression of atherosclerosis by attenuating hypercholesterolemia in type 1 diabetic Ins2+/Akita:apoE-/- mice. Atherosclerosis 2012, 225:341-347.
13. Hasty A.H., Shimano H., Osuga J., Namatame I., Takahashi A., Yahagi N., Perrey S., Iizuka Y., Tamura Y., Amemiya-Kudo M., Yoshikawa T., Okazaki H., Ohashi K., Harada K., Matsuzaka T., Sone H., Gotoda T., Nagai R., Ishibashi S., Yamada N. Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor. J. Biol. Chem. 2001, 276:37402-37408.
14. Mertens A., Verhamme P., Bielicki J.K., Phillips M.C., Quarck R., Verreth W., Stengel D., Ninio E., Navab M., Mackness B., Mackness M., Holvoet P. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis. Circulation 2003, 107:1640-1646.
15. Bodary P.F., Gu S., Shen Y., Hasty A.H., Buckler J.M., Eitzman D.T. Recombinant leptin promotes atherosclerosis and thrombosis in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2005, 25:e119-e122.
16. Zeadin M., Butcher M., Werstuck G., Khan M., Yee C.K., Shaughnessy S.G. Effect of leptin on vascular calcification in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2009, 29:2069-2075.
17. Schäfer K., Halle M., Goeschen C., Dellas C., Pynn M., Loskutoff D.J., Konstantinides S. Leptin promotes vascular remodeling and neointimal growth in mice. Arterioscler. Thromb. Vasc. Biol. 2004, 24:112-117.
18. de Luca C., Kowalski T.J., Zhang Y., Elmquist J.K., Lee C., Kilimann M.W., Ludwig T., Liu S.-M., Chua S.C. Complete rescue of obesity, diabetes, and infertility in db/db mice by neuron-specific LEPR-B transgenes. J. Clin. Invest. 2005, 115:3484-3493.
19. Teupser D., Pavlides S., Tan M., Gutierrez-Ramos J.-C., Kolbeck R., Breslow J.L. Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:17795-17800.
20. Isken F., Weickert M.O., Tschöp M.H., Nogueiras R., Möhlig M., Abdelrahman A., Klaus S., Thorens B., Pfeiffer A.F. Metabolic effects of diets differing in glycaemic index depend on age and endogenous glucose-dependent insulinotrophic polypeptide in mice. Diabetologia 2009, 52:2159-2168.
21. Paigen B., Morrow A., Holmes P.A., Mitchell D., Williams R.A. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 1987, 68:231-240.
22. Burkhardt R., Sündermann S., Ludwig D., Ceglarek U., Holdt L.M., Thiery J., Teupser D. Cosegregation of aortic root atherosclerosis and intermediate lipid phenotypes on chromosomes 2 and 8 in an intercross of C57BL/6 and BALBc/ByJ low-density lipoprotein receptor-/- mice. Arterioscler. Thromb. Vasc. Biol. 2011, 31:775-784.
23. Kralisch S., Klöting N., Ebert T., Kern M., Hoffmann A., Krause K., Jessnitzer B., Lossner U., Sommerer I., Stumvoll M., Fasshauer M. Circulating adipocyte fatty acid-binding protein induces insulin resistance in mice in vivo. Obesity 2015, 23:1007-1013.
24. Liang C.-P., Tall A.R. Transcriptional profiling reveals global defects in energy metabolism, lipoprotein, and bile acid synthesis and transport with reversal by leptin treatment in Ob/ob mouse liver. J. Biol. Chem. 2001, 276:49066-49076.
25. Shimomura I., Hammer R.E., Ikemoto S., Brown M.S., Goldstein J.L. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 1999, 401:73-76.
26. Singh A., Wirtz M., Parker N., Hogan M., Strahler J., Michailidis G., Schmidt S., Vidal-Puig A., Diano S., Andrews P., Brand M.D., Friedman J. Leptin-mediated changes in hepatic mitochondrial metabolism, structure, and protein levels. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:13100-13105.
27. Targher G., Bertolini L., Padovani R., Zoppini G., Zenari L., Falezza G. Letter to the editor: associations between liver histology and carotid intima-media thickness in patients with nonalcoholic fatty liver disease. Arterioscler. Thromb. Vasc. Biol. 2005, 25:2687-2688.
28. Alkhouri N., Tamimi T.-R., Yerian L., Lopez R., Zein N., Feldstein A. The inflamed liver and atherosclerosis: a link between histologic severity of nonalcoholic fatty liver disease and increased cardiovascular risk. Dig. Dis. Sci. 2010, 55:2644-2650.
29. Frühbeck G. Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes 1999, 48:903-908.
30. Frühbeck G., Gómez-Ambrosi J., Salvador J. Leptin-induced lipolysis opposes the tonic inhibition of endogenous adenosine in white adipocytes. FASEB J. 2001, 15:333-340.
31. Hui X., Lam K.S., Vanhoutte P.M., Xu A. Adiponectin and cardiovascular health: an update. Br. J. Pharmacol. 2012, 165:574-590.
32. Okamoto Y., Kihara S., Ouchi N., Nishida M., Arita Y., Kumada M., Ohashi K., Sakai N., Shimomura I., Kobayashi H., Terasaka N., Inaba T., Funahashi T., Matsuzawa Y. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 2002, 106:2767-2770.
33. Yamauchi T., Kamon J., Waki H., Imai Y., Shimozawa N., Hioki K., Uchida S., Ito Y., Matsui J., Eto K., Komeda K., Tsunoda M., Murakami K., Ohnishi Y., Yamamura K., Ueyama Y., Froguel P., Kimura S., Nagai R., Kadowaki T. Globular adiponectin protected ob/ob mice from diabetes and apoE deficient mice from atherosclerosis. J. Biol. Chem. 2003, 278:2461-2468.
34. Beltowski J. Leptin and atherosclerosis. Atherosclerosis 2006, 189:47-60.
35. Sweeney G. Leptin signalling. Cell. Signal. 2002, 14:655-663.
36. Park H.Y., Kwon H.M., Lim H.J., Hong B.K., Lee J.Y., Park B.E., Jang Y., Cho S.Y., Kim H.S. Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp. Mol. Med. 2001, 33:95-102.
37. Parhami F., Tintut Y., Ballard A., Fogelman A.M., Demer L.L. Leptin enhances the calcification of vascular cells: artery wall as a target of leptin. Circ. Res. 2001, 88:954-960.
38. Gómez-Ambrosi J., Salvador J., Páramo J.A., Orbe J., de Irala J., Diez-Caballero A., Gil M.J., Cienfuegos J.A., Frühbeck G. Involvement of leptin in the association between percentage of body fat and cardiovascular risk factors. Clin. Biochem. 2002, 35:315-320.
39. Chiba T., Shinozaki S., Nakazawa T., Kawakami A., Ai M., Kaneko E., Kitagawa M., Kondo K., Chait A., Shimokado K. Leptin deficiency suppresses progression of atherosclerosis in apoE-deficient mice. Atherosclerosis 2008, 196:68-75.